Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Additionally, we repurchased Bio-Rad Laboratories Inc. (BIO), a global leader in laboratory equipment and biological testing. Bio-Rad benefits from...
— Ariel Investments, LLC
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories ($BIO) develops, manufactures, and markets clinical diagnostics instruments and life sciences laboratory research systems, constituting 4.6% of the fund. The manager takes...
Bio-Rad Laboratories ($BIO), accounting for 3.0% of the strategy's assets, is a global life sciences instrumentation and clinical diagnostics equipment provider. The manager maintains...
Bio-Rad Laboratories ($BIO) is a life sciences and clinical diagnostics manufacturer that produces lab instruments, reagents, and test kits, while holding a non-consolidated 32% ownership stake in Sartorius AG. The manager initiated...
More institutional theses from Ariel Focus Fund
Chevron Corporation ($CVX) is a global integrated energy major that represented 4.6% of fund assets at the close of the quarter. The fund is...
FactSet Research Systems ($FDS) delivers mission-critical financial data, market analytics, and portfolio workflow solutions to asset managers, investment banks, and institutional advisors, representing 4.2% of the fund. The fund is...
APA Corporation ($APA) is an independent energy exploration and production company that constituted 5.2% of the fund's portfolio as of quarter-end. The fund maintains...